x

Posted 17 August, 2021

SWK Holdings Corp appointed new CEO

CEO Change detected for ticker Nasdaq:SWKH in a 8-K filed on 17 August, 2021.


  On August 11, 2021, the Board of Directors of SWK Holdings Corporation (the "Company"), upon the recommendation of its Compensation Committee, approved a bonus agreement with Winston L. Black, the Chief Executive Officer of the Company, in connection with the approval of bonus agreements with certain selected employees of the Company.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of SWK Holdings Corp
Technology • Software
SWK Holdings Corp. engages in financial and asset management in the field of pharmaceuticals. The company offers capital and investments in life science companies, institutions, and inventors. It operates through the Finance Receivables and Pharmaceutical Development segments. The Finance Receivables segment is a healthcare capital provider which offers customized financing solutions to a broad range of life science companies, institutions, and investors. It is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Pharmaceutical Development segment strategy is to utilize the Peptelligence platform to create a wholly-owned portfolio of milestone and royalty income by out-licensing the technology. The company was founded in July 1996 and is headquartered in Dallas, TX.
Market Cap
$204M
View Company Details
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Offices; Compensatory Arrangements of Certain Officers.

On August 11, 2021, the Board of Directors of SWK Holdings Corporation (the "Company"), upon the recommendation of its Compensation Committee, approved a bonus agreement with Winston L. Black, the Chief Executive Officer of the Company, in connection with the approval of bonus agreements with certain selected employees of the Company. The bonus agreements provide for special bonuses in the event the Company consummates a strategic corporate transaction before April 1, 2022. Subject to consummation of such a transaction, Mr. Black would receive approximately 50% of the bonus pool, 75% of which would be paid at closing of such transaction and 25% of which would be paid on the six-month anniversary of such closing, provided he remains employed through the closing and is not terminated with cause nor resigns without good reason prior to the second payment date, as well as executes and does not revoke a general release of claims against the Company, supports the transaction and complies with certain restrictive covenants.